oral semaglutide fda Novo Nordisk's Ozempic® pill, the only FDA-approved peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US FDA Approves RYBELSUS (oral semaglutide)

Sodium-glucose co-transporter type 2 inhibitors for the treatment of type 2 diabetes mellitus

GLP-1 medications also carry an FDA black box warning for risk of thyroid C-cell tumors, and should not be used by patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2)

Review Website, Ads, and Social Media Claims Marketing content should be evaluated regularly for statements that could create regulatory concerns

Because of this effect, Ozempic can help reduce your appetite

[PubMed] [Elsevier] Azzini E, Ruggeri S, Polito A

Neurochemical and behavioral studies on ethanol and nicotine interactions